Linked Life Data

16564661

Source:http://linkedlifedata.com/resource/pubmed/id/16564661

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2006-7-24
pubmed:abstractText
We used tacrolimus to successfully treat a patient with childhood-onset oropharyngeal myasthenia gravis (MG). A girl (2 years, 5 months old) with oropharyngeal MG responded partially to treatment including pyridostigmine bromide, intravenous immunoglobulin, and prednisolone (2 mg/kg/day) for 7 weeks, but this resulted in worsening of her eye symptoms. By contrast, tacrolimus at 2 mg/day resulted in complete remission of the MG, which made it possible to reduce the dose of prednisolone. This is a rare report of the use of tacrolimus as an effective treatment for patients with intractable childhood-onset MG.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0387-7604
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
534-6
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Successful treatment of a 2-year-old girl with intractable myasthenia gravis using tacrolimus.
pubmed:affiliation
Department of Pediatrics, Tohoku University School of Medicine, 1-1 Seiryo-Machi, Sendai, Miyagi, Japan. kakisuke@mui.biglobe.ne.jp
pubmed:publicationType
Journal Article, Case Reports